NCT04953052View on ClinicalTrials.gov

A Randomized Study to Investigate the Effect of Intravenous Imatinib on the Amount of Oxygen in the Lungs and Blood of Adults With COVID-19 Needing Mechanical Ventilation and Supportive Care.

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

October 14, 2021

Primary Completion Date

August 31, 2022

Study Completion Date

November 30, 2022

Conditions
Acute Respiratory Distress SyndromeCOVID-19 Acute Respiratory Distress SyndromeCovid19ARDSPulmonary Oedema
Interventions
DRUG

Imatinib Mesylate

An isotonic sterile solution of imatinib.

DRUG

Placebo

An isotonic sterile solution

Trial Locations (8)

390001

Sir Sayajirao General Hospital (SSG Hospital), Medical College Baroda, Jail Road Indira Avenue)Anandpura, Vadodara

400001

St George's Hospital, P D Mello Road, Fort Road, CST Terminal,, Mumbai

411018

PCMC PGI Yashwantrao Chavan Memorial Hospital, Nagar

440003

Government Medical College and Hospital, Nagpur

440018

Indira Gandhi Government Medical College and Hospital, Nagpur

570004

JSS Hospital, Mysuru

575002

Father Muller Hospital and Medical College, Mangalore

700014

NRS Medical College and Hospital, Kolkata

Sponsors

Lead Sponsor

Exvastat Ltd.
All Listed Sponsors
lead

Exvastat Ltd.

INDUSTRY

NCT04953052 - A Randomized Study to Investigate the Effect of Intravenous Imatinib on the Amount of Oxygen in the Lungs and Blood of Adults With COVID-19 Needing Mechanical Ventilation and Supportive Care. | Biotech Hunter | Biotech Hunter